Dalpiciclib Isetionate Tablets Clinical Trials

2 recruitingDrug

Phase 22Phase 11

Filters

Status

RecruitingNot yet recruitingEnrolling by invitationActive, not recruiting

Sex

MaleFemale

Your Age

Shows trials you qualify for by age

Phase

Phase 1Phase 2Phase 3Phase 4Early Phase 1Not Applicable

Study Type

InterventionalObservational

Country

United StatesCanadaUnited KingdomAustraliaGermanyFranceSpainItaly

Related Interventions

Fulvestrant injection8
Toripalimab Injection7
Camrelizumab (anti-PD-1 inhibitor)2
JS1052

Showing 1–2 of 2 trials

Recruiting

Phase 2

Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment

Hepatocellulcar Carcinoma

Sun Yat-sen University30 enrolled1 locationNCT07238881

Recruiting

Phase 1Phase 2

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

Advanced Solid Tumors

Risen (Suzhou) Pharma Tech Co., Ltd.306 enrolled1 locationNCT06208410

ClinicalTrialsFinder

Helping patients and researchers find recruiting clinical trials. Updated regularly from ClinicalTrials.gov and ANZCTR.

Browse

Browse Conditions
Browse Drugs
Browse Locations
Browse Institutions
Search Trials
Get Trial Alerts

Resources

Clinical Trial Guides
ClinicalTrials.gov
ANZCTR
NIH Clinical Research Info
FDA Patient Guide

Data Source

Trial data sourced from ClinicalTrials.gov and ANZCTR (Australian New Zealand Clinical Trials Registry)

Updated regularly to reflect the latest trial information

Medical Disclaimer: This site is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making decisions about participating in a clinical trial. Trial information may change; verify details directly with the trial sponsor or at the relevant registry (ClinicalTrials.gov or ANZCTR).

|

Privacy Policy Terms of Service

Data provided by ClinicalTrials.gov & ANZCTR